Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Azulon
2. Guajazulene
1. 489-84-9
2. 1,4-dimethyl-7-isopropylazulene
3. Vetivazulen
4. 7-isopropyl-1,4-dimethylazulene
5. Azulon
6. Kessazulen
7. Purazulen
8. Silazulon
9. Uroazulen
10. Azunol
11. S-guaiazulene
12. Eucazulen
13. Guajazulene
14. Guiazulene
15. Cuteazul
16. Gurjunazulen
17. Azulen-beris
18. Guaiazulen
19. 3,8-dimethyl-5-(2-propyl)azulene
20. Azulene, 1,4-dimethyl-7-(1-methylethyl)-
21. Vaumigan
22. 1,4-dimethyl-7-propan-2-ylazulene
23. 1,4-dimethyl-7-(1-methylethyl)azulene
24. Azulol
25. 1,4-dimethyl-7-(propan-2-yl)azulene
26. Eucazulene
27. Hepatoprotectant
28. Nsc 4714
29. Azulene, 7-isopropyl-1,4-dimethyl-
30. Az-8 Beris
31. Azunol (tn)
32. 7-isopropyl-1,4-dimethyl-azulene
33. Azulene, 1,4-dimethyl-7-isopropyl-
34. Nsc-4714
35. 2oz1k9jkqc
36. 1,3,5,7,9-guaiapentaene
37. Chebi:5550
38. 1,4-dimethyl-7-isopropyl-azulene
39. 1,4-dimethyl-7-isopropylazulene (jan)
40. Ncgc00095836-02
41. Dsstox_cid_25996
42. Dsstox_rid_81279
43. Dsstox_gsid_45996
44. Cas-489-84-9
45. 1,4-dimethyl-7-isopropylazulene [jan]
46. 7-isopropyl- 1,4-dimethylazulene
47. Einecs 207-701-2
48. Unii-2oz1k9jkqc
49. Brn 1365001
50. Guajazulen
51. Kessazulene
52. S-kessazulene
53. Guaiazulene, 99%
54. Mfcd00003811
55. Azulene,4-dimethyl-
56. Spectrum_001198
57. Guaiazulene [mi]
58. Spectrum2_001089
59. Spectrum3_001537
60. Spectrum4_000762
61. Spectrum5_001090
62. Guaiazulene [inci]
63. Guaiazulene [mart.]
64. Bspbio_002954
65. Guaiazulene [who-dd]
66. Kbiogr_001144
67. Kbioss_001678
68. 4-05-00-01751 (beilstein Handbook Reference)
69. Mls002207286
70. Divk1c_001006
71. Spectrum1502249
72. Spbio_001138
73. Az-8
74. 1,4-dimethyl-7-isopropylazulen
75. Chembl1408759
76. Dtxsid7045996
77. Hms503i13
78. Kbio1_001006
79. Kbio2_001678
80. Kbio2_004246
81. Kbio2_006814
82. Kbio3_002454
83. Azulene,4-dimethyl-7-isopropyl-
84. Nsc4714
85. Ninds_001006
86. 1, 4-dimethyl-7-isopropylazulene
87. Zinc968478
88. Hy-n6951
89. Tox21_111526
90. Bbl027440
91. Ccg-40099
92. S3995
93. Stk801958
94. Akos001082716
95. Tox21_111526_1
96. Db13329
97. Lmpr0103410006
98. Sdccgmls-0066686.p001
99. Wln: L57j B1 F1 Iy1&1
100. Idi1_001006
101. Azulene,4-dimethyl-7-(1-methylethyl)-
102. Ncgc00095836-01
103. Ncgc00095836-03
104. Ncgc00095836-05
105. Ncgc00178373-01
106. 1,4-dimethyl-7-(1-methylethyl)-azulene
107. As-13972
108. Smr001306801
109. Db-051592
110. Azulene, 7-isopropyl-1,4-dimethyl- (8ci)
111. Cs-0021588
112. Ft-0626818
113. G0228
114. 7-isopropyl-1,4-dimethyl-azulene;guaiazulene
115. 1,4-dimethyl-7-(1-methyl)-azulene (azulon)
116. 1,4-dimethyl-7-(1-methylethyl)azulene, 9ci
117. C09675
118. D01037
119. A827639
120. Sr-05000002441
121. Guaiazulene (constituent Of Chamomile) [dsc]
122. Q3026266
123. Sr-05000002441-1
124. Brd-k36719159-001-04-9
125. Z56347227
| Molecular Weight | 198.30 g/mol |
|---|---|
| Molecular Formula | C15H18 |
| XLogP3 | 4.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 0 |
| Rotatable Bond Count | 1 |
| Exact Mass | 198.140850574 g/mol |
| Monoisotopic Mass | 198.140850574 g/mol |
| Topological Polar Surface Area | 0 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 206 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
S - Sensory organs
S01 - Ophthalmologicals
S01X - Other ophthalmologicals
S01XA - Other ophthalmologicals
S01XA01 - Guaiazulen
Market Place
ABOUT THIS PAGE
A Guaiazulene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Guaiazulene, including repackagers and relabelers. The FDA regulates Guaiazulene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Guaiazulene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Guaiazulene supplier is an individual or a company that provides Guaiazulene active pharmaceutical ingredient (API) or Guaiazulene finished formulations upon request. The Guaiazulene suppliers may include Guaiazulene API manufacturers, exporters, distributors and traders.
click here to find a list of Guaiazulene suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Guaiazulene written confirmation (Guaiazulene WC) is an official document issued by a regulatory agency to a Guaiazulene manufacturer, verifying that the manufacturing facility of a Guaiazulene active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Guaiazulene APIs or Guaiazulene finished pharmaceutical products to another nation, regulatory agencies frequently require a Guaiazulene WC (written confirmation) as part of the regulatory process.
click here to find a list of Guaiazulene suppliers with Written Confirmation (WC) on PharmaCompass.
Guaiazulene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Guaiazulene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Guaiazulene GMP manufacturer or Guaiazulene GMP API supplier for your needs.
A Guaiazulene CoA (Certificate of Analysis) is a formal document that attests to Guaiazulene's compliance with Guaiazulene specifications and serves as a tool for batch-level quality control.
Guaiazulene CoA mostly includes findings from lab analyses of a specific batch. For each Guaiazulene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Guaiazulene may be tested according to a variety of international standards, such as European Pharmacopoeia (Guaiazulene EP), Guaiazulene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Guaiazulene USP).
LOOKING FOR A SUPPLIER?
